A peer-reviewed study published two days ago found that both the Moderna and the Pfizer vaccine trial data appeared to have a negative benefit/harm ratio. One of the authors of the paper is Peter Doshi, an associate editor of the British Medical Journal.
Using a prespecified list of adverse events of special interest (“AESI”) identified by the Brighton Collaboration, the study found a higher risk of serious AESI in the mRNA COVID-19 vaccine group relative to placebo in both the Pfizer and Moderna adult phase III trials.
“These results raise concerns that mRNA vaccines are associated with more harm than initially estimated at the time of emergency authorisation,” the study authors wrote.